Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats

D. Dunbar Ivy, Masashi Yanagisawa, Cheryl E. Gariepy, Sarah A. Gebb, Kelley L. Colvin, Ivan F. McMurtry

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Mechanisms by which endothelin (ET)-1 mediates chronic pulmonary hypertension remain incompletely understood. Although activation of the ET type A (ETA) receptor causes vasoconstriction, stimulation of ET type B (ETB) receptors can elicit vasodilation or vasoconstriction. We hypothesized that the ETB receptor attenuates the development of hypoxic pulmonary hypertension and studied a genetic rat model of ETB receptor deficiency (transgenic sl/sl). After 3 wk of severe hypoxia, the transgenic sl/sl pulmonary vasculature lacked expression of mRNA for the ETB receptor and developed exaggerated pulmonary hypertension that was characterized by elevated pulmonary arterial pressure, diminished cardiac output, and increased total pulmonary resistance. Plasma ET-1 was five-fold higher in transgenic sl/sl rats than in transgenic controls. Although mRNA for prepro-ET-1 was not different, mRNA for ET-converting enzyme-1 was higher in transgenic sl/sl than in transgenic control lungs. Hypertensive lungs of sl/sl rats also produced less nitric oxide metabolites and 6-ketoprostaglandin F, a metabolite of prostacyclin, than transgenic controls. These findings suggest that the ETB receptor plays a protective role in the pulmonary hypertensive response to chronic hypoxia.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume282
Issue number4 26-4
StatePublished - 2002

Fingerprint

Endothelin B Receptors
Pulmonary Hypertension
Lung
Endothelin-1
Vasoconstriction
Messenger RNA
Transgenic Rats
Endothelin A Receptors
Genetic Models
Epoprostenol
Vasodilation
Cardiac Output
Arterial Pressure
Nitric Oxide

Keywords

  • Endothelin receptors
  • Hypoxia
  • Nitric oxide
  • Prostacyclin
  • Pulmonary circulation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Cell Biology
  • Physiology

Cite this

Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats. / Dunbar Ivy, D.; Yanagisawa, Masashi; Gariepy, Cheryl E.; Gebb, Sarah A.; Colvin, Kelley L.; McMurtry, Ivan F.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 282, No. 4 26-4, 2002.

Research output: Contribution to journalArticle

Dunbar Ivy, D. ; Yanagisawa, Masashi ; Gariepy, Cheryl E. ; Gebb, Sarah A. ; Colvin, Kelley L. ; McMurtry, Ivan F. / Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2002 ; Vol. 282, No. 4 26-4.
@article{38bbdd80847745a09ee6f29e1fda694f,
title = "Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats",
abstract = "Mechanisms by which endothelin (ET)-1 mediates chronic pulmonary hypertension remain incompletely understood. Although activation of the ET type A (ETA) receptor causes vasoconstriction, stimulation of ET type B (ETB) receptors can elicit vasodilation or vasoconstriction. We hypothesized that the ETB receptor attenuates the development of hypoxic pulmonary hypertension and studied a genetic rat model of ETB receptor deficiency (transgenic sl/sl). After 3 wk of severe hypoxia, the transgenic sl/sl pulmonary vasculature lacked expression of mRNA for the ETB receptor and developed exaggerated pulmonary hypertension that was characterized by elevated pulmonary arterial pressure, diminished cardiac output, and increased total pulmonary resistance. Plasma ET-1 was five-fold higher in transgenic sl/sl rats than in transgenic controls. Although mRNA for prepro-ET-1 was not different, mRNA for ET-converting enzyme-1 was higher in transgenic sl/sl than in transgenic control lungs. Hypertensive lungs of sl/sl rats also produced less nitric oxide metabolites and 6-ketoprostaglandin Flα, a metabolite of prostacyclin, than transgenic controls. These findings suggest that the ETB receptor plays a protective role in the pulmonary hypertensive response to chronic hypoxia.",
keywords = "Endothelin receptors, Hypoxia, Nitric oxide, Prostacyclin, Pulmonary circulation",
author = "{Dunbar Ivy}, D. and Masashi Yanagisawa and Gariepy, {Cheryl E.} and Gebb, {Sarah A.} and Colvin, {Kelley L.} and McMurtry, {Ivan F.}",
year = "2002",
language = "English (US)",
volume = "282",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4 26-4",

}

TY - JOUR

T1 - Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats

AU - Dunbar Ivy, D.

AU - Yanagisawa, Masashi

AU - Gariepy, Cheryl E.

AU - Gebb, Sarah A.

AU - Colvin, Kelley L.

AU - McMurtry, Ivan F.

PY - 2002

Y1 - 2002

N2 - Mechanisms by which endothelin (ET)-1 mediates chronic pulmonary hypertension remain incompletely understood. Although activation of the ET type A (ETA) receptor causes vasoconstriction, stimulation of ET type B (ETB) receptors can elicit vasodilation or vasoconstriction. We hypothesized that the ETB receptor attenuates the development of hypoxic pulmonary hypertension and studied a genetic rat model of ETB receptor deficiency (transgenic sl/sl). After 3 wk of severe hypoxia, the transgenic sl/sl pulmonary vasculature lacked expression of mRNA for the ETB receptor and developed exaggerated pulmonary hypertension that was characterized by elevated pulmonary arterial pressure, diminished cardiac output, and increased total pulmonary resistance. Plasma ET-1 was five-fold higher in transgenic sl/sl rats than in transgenic controls. Although mRNA for prepro-ET-1 was not different, mRNA for ET-converting enzyme-1 was higher in transgenic sl/sl than in transgenic control lungs. Hypertensive lungs of sl/sl rats also produced less nitric oxide metabolites and 6-ketoprostaglandin Flα, a metabolite of prostacyclin, than transgenic controls. These findings suggest that the ETB receptor plays a protective role in the pulmonary hypertensive response to chronic hypoxia.

AB - Mechanisms by which endothelin (ET)-1 mediates chronic pulmonary hypertension remain incompletely understood. Although activation of the ET type A (ETA) receptor causes vasoconstriction, stimulation of ET type B (ETB) receptors can elicit vasodilation or vasoconstriction. We hypothesized that the ETB receptor attenuates the development of hypoxic pulmonary hypertension and studied a genetic rat model of ETB receptor deficiency (transgenic sl/sl). After 3 wk of severe hypoxia, the transgenic sl/sl pulmonary vasculature lacked expression of mRNA for the ETB receptor and developed exaggerated pulmonary hypertension that was characterized by elevated pulmonary arterial pressure, diminished cardiac output, and increased total pulmonary resistance. Plasma ET-1 was five-fold higher in transgenic sl/sl rats than in transgenic controls. Although mRNA for prepro-ET-1 was not different, mRNA for ET-converting enzyme-1 was higher in transgenic sl/sl than in transgenic control lungs. Hypertensive lungs of sl/sl rats also produced less nitric oxide metabolites and 6-ketoprostaglandin Flα, a metabolite of prostacyclin, than transgenic controls. These findings suggest that the ETB receptor plays a protective role in the pulmonary hypertensive response to chronic hypoxia.

KW - Endothelin receptors

KW - Hypoxia

KW - Nitric oxide

KW - Prostacyclin

KW - Pulmonary circulation

UR - http://www.scopus.com/inward/record.url?scp=0036082822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036082822&partnerID=8YFLogxK

M3 - Article

VL - 282

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 4 26-4

ER -